Oncimmune: Oncimmune shares surge on contract wins
Shares in autoantibody profiling company Oncimmune surged on Monday after the group revealed that it had made "strong commercial progress" since its last update back in May.
Read full article »
CEO
- -Oncimmune is an England-based biotechnology company that develops an analytical platform for the discovery of immunodiagnostic antibody biomarker signatures.
Read more